$SOARJun 26, 2026, 9:10 PMAI processedSCHEDULE 13G
Catheter Precision buys 2.94M SOAR shares (7.5%) in private placement
AI Summary
AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 Volato Group, Inc. filed SEC Form SCHEDULE 13G. Catheter Precision, Inc. acquired 2,941,176 shares of Volato Group, Inc. (NYSE American: SOAR) pursuant to a Securities Purchase Agreement, with the closing on June 18, 2026. The Schedule 13G filing reports that this equals 7.5% of the issued common stock (based on 39,336,982 shares outstanding after the placement) and states the shares are held with sole voting and dispositive power while the purchaser certifies passive intent.
Positives
- Acquired 2,941,176 shares of Volato Group (SOAR), representing 7.5% of outstanding shares.
- Shares were purchased in a private placement under a Securities Purchase Agreement that closed on June 18, 2026.
- Reporting person (Catheter Precision) reports sole voting and sole dispositive power over the shares.
Negatives
- Issuer's S‑3 indicates shares outstanding rose to 39,336,982 after the private placement, increasing dilution to prior holders.
- Filing certifies the purchase was not made to influence control, indicating passive intent and no immediate activist pressure.